COPENHAGEN, Denmark and MUNICH, Sept. 17, 2024 /PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS) ...
Dec 24 (Reuters) - Sanofi (SASY.PA) said on Wednesday it will buy U.S. biotech Dynavax Technologies (DVAX.O) for around $2.2 ...
Shares of Meta Platforms (NASDAQ: META) have advanced 13% year to date, bringing its market value to $1.6 trillion. Meanwhile ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for an IPO to fund development of vaccines that could compete with companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback